Zuplenz FDA Approval History
FDA Approved: Yes (First approved July 2, 2010)
Brand name: Zuplenz
Generic name: ondansetron
Dosage form: Oral Soluble Film
Company: Strativa Pharmaceuticals
Treatment for: Nausea/Vomiting, Chemotherapy Induced, Nausea/Vomiting, Postoperative, Nausea/Vomiting, Radiation Induced
Zuplenz is an oral soluble film formulation of ondansetron for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.
Development Timeline for Zuplenz
|Jul 5, 2010||FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.